The Incidence and Severity of Drug Interactions Before and After Switching Antiretroviral Therapy to Bictegravir/Emtricitabine/Tenofovir Alafenamide in Treatment Experienced Patients

NCT03789968 · clinicaltrials.gov ↗
COMPLETED
Status
411
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Thomas Jefferson University

Collaborators